2022 By Chris Brown September 15, 2022 0 Comments Nugen Medical Devices Announces Application To Amend Warrants Nugen Medical Devices Announces Application To Amend Warrants TORONTO, ON / ACCESSWIRE / September 15, 2022 / NuGen Medical Devices Inc. (TSXV:NGMD) (the “Company“) is pleased to announce that it has made an application to the TSX Venture »
2022 By Chris Brown September 12, 2022 0 Comments NuGen M.D. Announces DTC Eligibility Within the United States NuGen M.D. Announces DTC Eligibility Within the United States TORONTO, Ontario – September 12, 2022 – NuGen Medical Devices Inc. (TSXV:NGMD) (OTCQB:NGMDF) (“NuGen” or the “Company”), a leader in needle-free drug delivery, is pleased to announce that, effective September 9, »
2022 By Chris Brown September 9, 2022 0 Comments Nugen Medical Devices Announces Closing of Private Placement of Units and Convertible Debentures Nugen Medical Devices Announces Closing of Private Placement of Units and Convertible Debentures TORONTO, ON / ACCESSWIRE / September 8, 2022 / NuGen Medical Devices Inc. (TSXV:NGMD) (the “Company“) is pleased to announce, further to its press releases »
2022 By Chris Brown August 22, 2022 0 Comments NuGen Applies for Extension of Price Protection for Private Placement NuGen Applies for Extension of Price Protection for Private Placement Toronto, Ontario–(Newsfile Corp. – August 10, 2022) – NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company“) announces that in connection with the private placement (the “Offering“) »
2022 By Chris Brown July 27, 2022 0 Comments NuGen M.D. Commences Trading on OTCQB Under The Symbol ‘NGMDF’ NuGen M.D. Commences Trading on OTCQB Under The Symbol ‘NGMDF’ TORONTO, Ontario – July 27, 2022 – NuGen Medical Devices Inc. (TSXV: NGMD) (OTCQB:NGMDF) (“NuGen” or the “Company”), a leader in needle-free drug delivery, is pleased to announce that, effective »
2022 By Chris Brown July 21, 2022 0 Comments NuGen M.D. Receives Additional Health Canada Approval for Insulin Specific Needle-Free Injection System NuGen M.D. Receives Additional Health Canada Approval for Insulin Specific Needle-Free Injection System TORONTO, Ontario – July 21, 2022 – NuGen Medical Devices Inc. (TSXV: NGMD) (“NuGen” or the “Company”), a leader in needle-free drug delivery, is pleased to announce »
2022 By Chris Brown July 5, 2022 0 Comments NuGen M.D. Signs Exclusive Sales and Distribution Deal with Leading Global Healthcare Company Sol-Millenium for Canadian and Brazilian Diabetes Market NuGen M.D. Signs Exclusive Sales and Distribution Deal with Leading Global Healthcare Company Sol-Millenium for Canadian and Brazilian Diabetes Market Includes Initial Purchase Order for 500 Needle-Free Devices and Minimum Commitment of 14,250 Devices TORONTO, Ontario – July 05, 2022 »
2022 By Chris Brown June 21, 2022 0 Comments NuGen M.D. Launches PetJet™ Providing Needle-Free Injections for Domesticated Pets NuGen M.D. Launches PetJet™ Providing Needle-Free Injections for Domesticated Pets Reducing Fear and Risk of Injury for Pet Owners and their Furry Loved Ones TORONTO, Ontario – June 22, 2022 – NuGen Medical Devices Inc. (TSXV: NGMD) (“NuGen” or the »
2022 By Chris Brown June 17, 2022 0 Comments NuGen Announces Results of its Annual and Special Meeting and Approval of Amendments to Stock Option Plan NuGen Announces Results of its Annual and Special Meeting and Approval of Amendments to Stock Option Plan Toronto, Ontario – June 17, 2022 – NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company”) is pleased to announce that all »
2022 By Chris Brown June 15, 2022 0 Comments NuGen M.D. Submits for FDA Emergency Use Authorization Approval for its Needle-Free Injection Systems NuGen M.D. Submits for FDA Emergency Use Authorization Approval for its Needle-Free Injection Systems TORONTO, Ontario – June 15, 2022 – NuGen Medical Devices Inc. (TSXV: NGMD) (“NuGen” or the “Company”), a leader in needle-free drug delivery, in collaboration with »
